Collection company Portfolio Recovery Associates is reporting double digit revenue growth and its stock is soaring. Steven Fredrickson, the company's CEO, tells CNBC how he plans to keep up the momentum.
Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.
Douglas Roberts, of ChannelCapitalResearch.com, and Dean Barber, of the Barber Financial Group, share their investment strategies and favorite sectors with CNBC.